Journal
ANTIVIRAL RESEARCH
Volume 92, Issue 2, Pages 369-371Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2011.08.003
Keywords
Glucosidase inhibitor; Dengue virus; Lethal infection mouse model
Categories
Funding
- NIH [AI061441, AI084267-0109]
- Hepatitis B Foundation, Commonwealth of Pennsylvania
Ask authors/readers for more resources
Dengue virus infection causes diseases in people, ranging from the acute febrile illness dengue fever, to life-threatening dengue hemorrhagic fever/dengue shock syndrome. We previously reported that a host cellular alpha-glucosidases I and II inhibitor, imino sugar CM-10-18, potently inhibited dengue virus replication in cultured cells, and significantly reduced viremia in dengue virus infected AG129 mice. In this report we show that CM-10-18 also significantly protects mice from death and/or disease progress in two mouse models of lethal dengue virus infection. Our results thus provide a strong support for the development of CM-10-18 or its derivatives as antiviral agents to treat servere dengue virus infections. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available